Gene therapy developed by Dr. Maria Castro and Dr. Pedro Lowenstein will now get the first test in human patients. The experimental approach, based on their research while at the University of Michigan, delivers two different genes directly into the brains of patients following the operation to remove the bulk of their tumors.
QVC and FFANY presented a check for $342,143 to the Cancer Center's Breast Oncology Program, one of nine beneficiaries of the 2013 QVC Presents "FFANY Shoes on Sale" event, in which 75,000 pairs of shoes were ordered at half the manufacturer’s suggested retail price, all in the name of cancer awareness.
Like a stealth fighter jet, the coating means the cells evade detection by the early-warning immune system that should detect and kill them. The stealth approach lets the tumors hide until it’s too late for the body to defeat them.
Analysis of the gut microbiome more successfully distinguished healthy individuals from those with precancerous adenomatous polyps and those with invasive colorectal cancer compared with assessment of clinical risk factors and fecal occult blood testing, according to a new study.
The second annual Maize and Blue Go Pink gala will be Aug. 21 at the Somerset Collection. The evening includes a fashion-focused live auction followed by a progressive culinary and wine experience from favorite Detroit and Ann Arbor restaurants. It all benefits breast cancer research at the U-M Comprehensive Cancer Center.
University of Michigan researchers have found that a particular protein -- TRIP13 -- encourages those cancer cells to repair themselves. And they have identified an existing chemical that blocks this mechanism for cell repair. And they have identified an existing chemical that blocks this mechanism for cell repair. "This is a very significant advance, because identifying the function of the protein that fuels the repair of cancer cells and having an existing chemical that blocks the process, could speed the process of moving to clinical trials," said principal investigator Nisha D'Silva, U-M professor of dentistry and associate professor of pathology.
The number of younger men diagnosed with prostate cancer has increased nearly 6-fold in the last 20 years, and the disease is more likely to be aggressive in these younger men, according to a new analysis.
African-Americans with colon cancer are half as likely as Caucasian patients to have a type of colon cancer that is linked to better outcomes. The finding may provide insight into why African-Americans are more likely to die of colon cancer than Caucasians with the same stage of disease.
In the last 30 years, since mammography was introduced, late-stage breast cancer incidence has decreased by 37 percent, a new study from the University of Michigan Comprehensive Cancer Center finds.
Among men treated for prostate cancer, those who received radiation therapy were more likely to develop bladder or rectal cancer, according to a new study.